sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Core D: Nonhuman Primates

$1,527,673

Francois J Villinger · University Of Washington · P01 · FY2022 · AI

Constructing the nest - understanding the mechanisms of nidoviridae RNA genomes transcription and recombination

$1,525,500

Silvia Rouskin · Harvard Medical School · DP2 · FY2022 · AI

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

$1,524,793

Lawrence C Kleinman · Rutgers Biomedical And Health Sciences · R33 · FY2023 · HD

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

$1,517,692

Lawrence C Kleinman · Rutgers Biomedical And Health Sciences · R33 · FY2023 · HD

NIEHS Knock Out Mouse Core (KOMC) Annual Report

$1,517,648

Manas Ray · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES

Development of PLpro and 3CLpro Protease Inhibitors as Novel SARS Therapeutics

$1,517,021

Michael E. Johnson · University Of Illinois At Chicago · R56 · FY2010 · AI

A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients

$1,516,672

Cedric Manlhiot · Johns Hopkins University · R33 · FY2023 · HD

Viral Vector Core

$1,516,365

Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES

High Throughput Next Generation Sequencing: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases

$1,514,820

Stefania Dell'orso · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2022 · AR

Structural study of the HIV1 gp41 coat protein

$1,513,712

Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Adaptive Immunity and Persistent SARS-CoV-2 Replication

$1,512,103

Suresh B Boppana · University Of Alabama At Birmingham · U01 · FY2023 · CA

Stanford/UNC Biomimetic U19 Research Center

$1,511,551

Calvin J Kuo · Stanford University · U19 · FY2022 · AI

Microfabrication for Biomedical Research

$1,510,844

Nicole Y Morgan · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2024 · EB

Novel Protease Inhibitors as SARS Therapeutics

$1,510,698

Michael E. Johnson · University Of Illinois At Chicago · P01 · FY2008 · AI

CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2

$1,509,136

Thomas Denny · Duke University · N01 · FY2023 · AI

Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions to Maximize Migrant Children's School Attendance During the COVID-19 Pandemic

$1,508,470

Russell James McCulloh · University Of Nebraska Medical Center · OT2 · FY2021 · HD

Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination

$1,507,637

Pamela J Bjorkman · Rockefeller University · P01 · FY2022 · AI

Enhancing dengue virus genomic surveillance to uncover circulating genetic diversity

$1,507,500

Nathan Dale Grubaugh · Yale University · DP2 · FY2022 · AI

Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)

$1,504,860

Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies

$1,504,401

Bryan Lau · Johns Hopkins University · R01 · FY2025 · AI

RBD recombinant protein-based SARS vaccine for biodefense

$1,501,840

Peter J Hotez · Baylor College Of Medicine · R01 · FY2012 · AI

Stanford/UNC Biomimetic U19 Research Center

$1,501,000

Calvin J Kuo · Stanford University · U19 · FY2023 · AI

Core D: Nonhuman Primates

Constructing the nest - understanding the mechanisms of nidoviridae RNA genomes transcription and recombination

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

Personalized Environment and Genes Study (PEGS)

Human monoclonal antibodies targeting infectious pathogens

Virus Ecology Unit - COVID-19 response

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

NIEHS Knock Out Mouse Core (KOMC) Annual Report

Development of PLpro and 3CLpro Protease Inhibitors as Novel SARS Therapeutics

A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients

Viral Vector Core

High Throughput Next Generation Sequencing: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases

Structural study of the HIV1 gp41 coat protein

Adaptive Immunity and Persistent SARS-CoV-2 Replication

Stanford/UNC Biomimetic U19 Research Center

Microfabrication for Biomedical Research

Novel Protease Inhibitors as SARS Therapeutics

CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2

Mobile Health-Targeted SARS-CoV-2 Testing and Community Interventions to Maximize Migrant Children's School Attendance During the COVID-19 Pandemic

Structural Characterization of Coronavirus Antibodies Raised by Infection and Vaccination

Enhancing dengue virus genomic surveillance to uncover circulating genetic diversity

Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)

At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies

RBD recombinant protein-based SARS vaccine for biodefense

Stanford/UNC Biomimetic U19 Research Center